drugset / Trial / NCT03527966
rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures
RandomizedParallel-groupDouble-blindBasic science
Summary
This study is aimed at comparing the overall efficacy (clinical and radiographic) of Vivigen, a novel cellular allograft product, and rhBMP-2 when utilized in lumbar fusion procedures.
Timeline
- Start
- 2017-07-03
- Primary completion
- 2018-07-27
- Completion
- 2018-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vivigen | Cell therapy | 5 ml | — |
| Comparator | rhBMP-2 | Protein / enzyme biologic | — | — |